SURFACE THERAPEUTICS LTD.
Surface Therapeutics Ltd. is a privately owned drug discovery and development company that is developing new pharmaceutical products for the treatment of inflammatory epithelial diseases; inflammatory conditions of the surfaces of the body, with a focus on the skin and lungs.
SURFACE THERAPEUTICS LTD.
Industry:
Health Care Pharmaceutical
Founded:
2004-01-01
Address:
Abingdon, Oxfordshire, United Kingdom
Country:
United Kingdom
Total Employee:
1+
Status:
Active
Total Funding:
1.5 M GBP
Similar Organizations
ACS Division of Medicinal Chemistry
ACS Division of Medicinal Chemistry is a professional organization for drug discovery and development scientists.
DS Biopharma
DS Biopharma is a privately held drug discovery and development company.
Exo Therapeutics
Exo Therapeutics is a small molecule drug discovery and development company.
Griffin Discoveries
Griffin Discoveries B.V. is a privately-owned drug discovery company.
Summit Therapeutics
Summit Therapeutics is a clinical-stage drug discovery and development company.
Investors List
East Hill Management
East Hill Management investment in Series A - Surface Therapeutics Ltd.
East Hill Management
East Hill Management investment in Seed Round - Surface Therapeutics Ltd.
More informations about "Surface Therapeutics Ltd."
Surface Therapeutics 2025 Company Profile: Valuation, Investors ...
Surface Therapeutics’s primary industry is Drug Discovery. Is Surface Therapeutics a private or public company? Surface Therapeutics is a Private company. What is Surface Therapeutics’s …See details»
Surface Therapeutics Ltd. - Funding, Financials, Valuation
Surface Therapeutics Ltd. is a privately owned drug discovery and development company. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …See details»
Surface Therapeutics - Ownership and Business Overview - Mergr
Sep 24, 2007 Surface Therapeutics, Ltd. develops drugs and diagnostics for asthma, childhood eczema, and other allergic diseases. Company Summary. SECTOR. Life Science. …See details»
Surface Therapeutics - Products, Competitors, Financials, …
Surface Therapeutics is a drug discovery and development company developing innovative new drugs to treat inflammatory epithelial diseases of the skin and lungs. Surface Therapeutics …See details»
Surface Therapeutics Ltd - Company Profile and News
Company profile page for Surface Therapeutics Ltd including stock price, company news, executives, board members, and contact informationSee details»
Surface Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore Surface Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
Surface Therapeutics Ltd. Asset Profile - Preqin
Surface Therapeutics Ltd is a UK-based company that operates as a developer of drugs and diagnostics for asthma, childhood eczema, and other allergic diseases. Current Investors …See details»
Surface Therapeutics Ltd. - Tech Stack, Apps, Patents ... - Crunchbase
Surface Therapeutics Ltd. is a privately owned drug discovery and development company.See details»
Surface Therapeutics Ltd. - life-sciences-europe.com
Nestlé to Acquire Vowst Assets from Seres Therapeutics; Leon-Nanodrugs Closes Series D Led by LBBW Venture Capital; AIRNA Raises $60m Series A Extension Led by Forbion; …See details»
Surface Therapeutics. - VentureRadar
Oxagen United Kingdom Privately Held Oxagen Limited is a privately held UK biopharmaceutical company developing a pipeline of novel small molecule drugs addressing asthma and other …See details»
Surface Therapeutics Limited Company Profile, Financial and
DigitGaps report on Surface Therapeutics Limited delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses and structures, and …See details»
Surface Therapeutics Ltd. (Surface Therapeutics Ltd.) - 药物管线_专 …
了解Surface Therapeutics Ltd. (Surface Therapeutics Ltd.)公司的药物管线，治疗领域，技术平台，以及它的1篇新闻。See details»
Surface Therapeutics CEO, Founder, Key Executive Team, Board of ...
Explore {Surface Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Surface …See details»
Surface Therapeutics Ltd.: 药物管线，专利，临床试验 - 智慧芽新 …
了解Surface Therapeutics Ltd.公司的药物管线，治疗领域，技术平台，以及它的。See details»
STP-01b - Drug Targets, Indications, Patents - Synapse - Patsnap
STP-01b: a Protease inhibitors Drug, Initially developed by Surface Therapeutics Ltd., Now, its global highest R&D status is Pending, Mechanism: Protease inhibitors, Therapeutic Areas: …See details»
Serentis acquires Surface Therapeutics Ltd. - Crunchbase
Oct 2, 2007 Serentis acquires Surface Therapeutics Ltd. on 2007-10-02 for an undisclosed amount. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... Save . …See details»
David Laskow-Pooley: Positions, Relations and Network
Nov 30, 2008 Surface Therapeutics Ltd. develops novel drugs & diagnostics for asthma and epithelial diseases. It also develops new pharmaceutical products for the treatment of …See details»
Surface Active Therapeutics launched by BioInteractions
Feb 4, 2025 BioInteractions has announced the launch of Surface Active Therapeutics, a medical technology which it says is poised to revolutionise the safety and efficacy of medical …See details»
Tribune gains funds to advance scar tissue therapies
23 hours ago Tribune Therapeutics has secured €37m ($39.9m) in seed and Series A funding to propel its therapy portfolio aimed at the central drivers of scar tissue formation. The financial …See details»
Serentis - Crunchbase Company Profile & Funding
Organization. Serentis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Serentis acquired Surface Therapeutics Ltd. for an …See details»